Skip NavigationSkip to Content
Return Return to Search Results

Nitric oxide, a mediator of inflammation, suppresses tumorigenesis

  1. Author:
    Hussain, S. P.
    Trivers, G. E.
    Hofseth, L. J.
    He, P. J.
    Shaikh, I.
    Mechanic, L. E.
    Doja, S.
    Jiang, W. D.
    Subleski, J.
    Shorts, L.
    Haines, D.
    Laubach, V. E.
    Wiltrout, R. H.
    Djurickovic, D.
    Harris, C. C.

  2. Author Address

    NCI, Lab Human Carcinogenet, NIH, Ctr Canc Res, Bethesda, MD 20892 USA. Univ S Carolina, Coll Pharm, Dept Basic Pharmaceut Sci, Columbia, SC USA. NCI, Lab Expt Immunol, Frederick, MD USA. Sci Applicat Int Corp, Lab Anim Sci Program, NCI, Frederick, MD USA. Univ Virginia, Hlth Sci Ctr, Dept Surg, Charlottesville, VA USA. Dev Ctr, Frederick, MD USA Harris, CC, NCI, Lab Human Carcinogenet, NIH, Ctr Canc Res, Bldg 37,Room 3068, Bethesda, MD 20892 USA
    1. Year: 2004
    2. Date: OCT 1
  2. Journal: Cancer Research
    1. 64
    2. 19
    3. Pages: 6849-6853
  4. Type of Article: Article
  1. Abstract:

    Inflammation influences the development of cancer. The nitric oxide synthase (NOS2) is induced by inflammatory cytokines, e.g., tumor necrosis factor alpha and interleukin 1beta, and produces nitric oxide (NO.), a critical mediator of the inflammatory response. Because p53 governs NO. production by transcriptionally transrepressing NOS2, we used a genetic strategy to determine whether NO. and p53 cooperatively regulate tumorigenesis. Lymphomas developed more rapidly in p53-/-NOS2-/- or p53-/-NOS2 +/- mice than in p53-/-NOS2+/+ mice that were crossbred into a >95% C57BL6 background and maintained in a pathogen-free condition. Likewise, sarcomas and lymphomas developed faster in p53+/-NOS2-/- or p53+/-NOS2+/- than in p53+/-NOS2+/+ mice. When compared with the double knockout mice, p53-/-NOS2+/+ mice showed a higher apoptotic index and a decreased proliferation index with an increased expression of death receptor ligands, CD95-L and tumor necrosis factor-related apoptosis-inducing ligand, and the cell cycle checkpoint protein, p21(waf1), in the spleen and thymus before tumor development. Furthermore, mice deficient in both p53 and NOS2 produced a high level of anti-inflammatory interleukin 10 when compared with p53-deficient mice. These studies provide genetic and mechanistic evidence that NO. can suppress. tumorigenesis

    See More

  1. Keywords:

External Sources

  1. View record in Web of Science®
  2. WOS: 000224292400004

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel